Company

ProJenX

Biotechnology Research New York, Ny, United States 7 employees

Employees: 7
Contacts: 2
Emails: 2

www.projenx.com LinkedIn Crunchbase

ProJenX Overview

Headquarters: New York, Ny, United States
Website: www.projenx.com
Industry: Biotechnology Research
Employees: 7
Founded: 2021
Funding: 1.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Neuroscience Motor Neurons Neurology

About ProJenX

ProJenX is a clinical-stage biotechnology company with novel, targeted, brain-penetrant therapies to address neurodegenerative diseases, with an initial focus on ALS. ProJenX was created out of a long-term research collaboration between Project ALS and Columbia University to rapidly develop and commercialize its lead therapy candidate, prosetin, for people with ALS. At the heart of ProJenX’s discoveries is an innovative, patient-specific, cell-based discovery platform that can be leveraged for the creation of additional transformative neuroscience medicines.

ProJenX Contact Details

People in AeroLeads: 2
With contact data: 2
Email contacts: 2; 100.0% coverage

ProJenX Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ingela Danielsson, Md. Ph.d. Mba	CMO, Gene Vector Institute	San Antonio, Texas, United States	Email
Margot Shanahan	Executive Director, Project Als	Brooklyn, New York, United States	Email